These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34643248)

  • 1. Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway.
    Guo XH; Jiang SS; Zhang LL; Hu J; Edelbek D; Feng YQ; Yang ZX; Hu PC; Zhong H; Yang GH; Yang F
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34643248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway.
    Wang Q; Wu H; Wu Q; Zhong S
    Drug Dev Res; 2023 Aug; 84(5):907-921. PubMed ID: 37070571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine regulates mesangial cell proliferation and cell cycle to attenuate diabetic nephropathy through the PI3K/Akt/AS160/GLUT1 signalling pathway.
    Ni WJ; Guan XM; Zeng J; Zhou H; Meng XM; Tang LQ
    J Cell Mol Med; 2022 Feb; 26(4):1144-1155. PubMed ID: 35001506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
    Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
    J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells.
    Li G; Zhang C; Liang W; Zhang Y; Shen Y; Tian X
    Pharm Biol; 2021 Dec; 59(1):21-30. PubMed ID: 33417512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
    Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
    J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotranscriptomic profiling of resistant triple-negative breast cancer cells treated with lapatinib and berberine shows upregulation of PI3K/Akt signaling under cytotoxic stress.
    Jabbarzadeh Kaboli P; Luo S; Chen Y; Jomhori M; Imani S; Xiang S; Wu Z; Li M; Shen J; Zhao Y; Wu X; Hin Cho C; Xiao Z
    Gene; 2022 Mar; 816():146171. PubMed ID: 35026293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Glut1 gene silencing on proliferation, differentiation, and apoptosis of colorectal cancer cells by targeting the TGF-β/PI3K-AKT-mTOR signaling pathway.
    Wu XL; Wang LK; Yang DD; Qu M; Yang YJ; Guo F; Han L; Xue J
    J Cell Biochem; 2018 Feb; 119(2):2356-2367. PubMed ID: 28884839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways.
    Zhang Q; Wang X; Cao S; Sun Y; He X; Jiang B; Yu Y; Duan J; Qiu F; Kang N
    Biomed Pharmacother; 2020 Aug; 128():110245. PubMed ID: 32454290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine attenuates apoptosis in rat retinal Müller cells stimulated with high glucose via enhancing autophagy and the AMPK/mTOR signaling.
    Chen H; Ji Y; Yan X; Su G; Chen L; Xiao J
    Biomed Pharmacother; 2018 Dec; 108():1201-1207. PubMed ID: 30372821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth.
    Fu L; Chen W; Guo W; Wang J; Tian Y; Shi D; Zhang X; Qiu H; Xiao X; Kang T; Huang W; Wang S; Deng W
    PLoS One; 2013; 8(7):e69240. PubMed ID: 23869238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation.
    Song L; Luo Y; Wang X; Almutairi MM; Pan H; Li W; Liu Y; Wang Q; Hong M
    Mol Med Rep; 2019 Nov; 20(5):4654-4664. PubMed ID: 31545468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine decelerates glucose metabolism via suppression of mTOR‑dependent HIF‑1α protein synthesis in colon cancer cells.
    Mao L; Chen Q; Gong K; Xu X; Xie Y; Zhang W; Cao H; Hu T; Hong X; Zhan YY
    Oncol Rep; 2018 May; 39(5):2436-2442. PubMed ID: 29565467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
    Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
    Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S; Rizvi F; Raisuddin S; Kakkar P
    Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
    Liu L; Fan J; Ai G; Liu J; Luo N; Li C; Cheng Z
    Biol Res; 2019 Jul; 52(1):37. PubMed ID: 31319879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine inhibits the proliferation, invasion and migration of endometrial stromal cells by downregulating miR‑429.
    Gu Y; Zhou Z
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
    Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
    Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine berberine.
    Lee KH; Lo HL; Tang WC; Hsiao HH; Yang PM
    Sci Rep; 2014 Sep; 4():6394. PubMed ID: 25227736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism.
    Chen GQ; Tang CF; Shi XK; Lin CY; Fatima S; Pan XH; Yang DJ; Zhang G; Lu AP; Lin SH; Bian ZX
    Oncotarget; 2015 Sep; 6(27):24148-62. PubMed ID: 26160839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.